2013
DOI: 10.1016/j.bjid.2013.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis

Abstract: Patients with hepatitis C virus-related decompensated cirrhosis can benefit from interferon-based antiviral therapy, but the common complication of cytopenia is a contraindication for this treatment. Splenectomy prior to interferon therapy may alleviate this problem. To investigate whether splenectomy improves the efficacy of antiviral therapy, 13 interferon-naïve hepatitis C virus decompensated cirrhotic patients underwent splenectomy between January 2008 and January 2011, followed 1-3 months later by an inte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 23 publications
1
5
0
Order By: Relevance
“…Previous studies have also reported splenectomy to increase the efficacy of liver transplantation and improve the prognosis of hepatocellular carcinoma [7779]. A study by Ogawa et al has also suggested splenectomy as a supplemental treatment for anti-HCV therapy in combination with interferons and other pharmaceuticals, which is consistent with our own finding [80, 81]. Although animal studies suggest that splenectomy can ameliorate collagen deposition, improve liver function and regeneration capacity and enhance the therapeutic efficacy of stem cell transplantations [6, 59, 75], many cirrhosis patients present with contraindications which preclude splenectomy.…”
Section: Targeting Spleen For the Treatment Of Liver Cirrhosissupporting
confidence: 89%
“…Previous studies have also reported splenectomy to increase the efficacy of liver transplantation and improve the prognosis of hepatocellular carcinoma [7779]. A study by Ogawa et al has also suggested splenectomy as a supplemental treatment for anti-HCV therapy in combination with interferons and other pharmaceuticals, which is consistent with our own finding [80, 81]. Although animal studies suggest that splenectomy can ameliorate collagen deposition, improve liver function and regeneration capacity and enhance the therapeutic efficacy of stem cell transplantations [6, 59, 75], many cirrhosis patients present with contraindications which preclude splenectomy.…”
Section: Targeting Spleen For the Treatment Of Liver Cirrhosissupporting
confidence: 89%
“…The remaining 30 patients were enrolled into the study (Fig. 1 ) included 13 treatment-experienced patients [ 8 , 11 , 32 , 33 ] and 17 treatment-naïve patients.
Fig.
…”
Section: Methodsmentioning
confidence: 99%
“…Although the guidelines indicated splenectomy can be a useful way to increase platelet count for these patients, these studies were small; only a few successful cases reported specifically on these patients whose platelet count was more than 50×10 9 /l, guaranteeing the success of operation [9][10][11][12]. We seldom found case reports in which platelets were as low as below 10×10 9 /l with splenectomy.…”
Section: Discussionmentioning
confidence: 92%